Clenbuterol treatment affects myosin heavy chain isoforms and MyoD content similarly in intact and regenerated soleus muscles.
D000318:Adrenergic beta-Agonists / Q000494:pharmacology*; D000818:Animals; D015153:Blotting, Western / Q000379:methods; D001835:Body Weight / Q000502:physiology; D002976:Clenbuterol / Q000494:pharmacology*; D005260:Female; D007150:Immunohistochemistry / Q000379:methods; D007536:Isomerism; D018485:Muscle Fibers, Skeletal / Q000187:drug effects / Q000378:metabolism; D018482:Muscle, Skeletal / Q000033:anatomy & histology / Q000187:drug effects* / Q000378:metabolism; D017570:MyoD Protein / Q000032:analysis*; D018995:Myosin Heavy Chains / Q000187:drug effects* / Q000378:metabolism; D009929:Organ Size / Q000502:physiology; D051381:Rats; D017208:Rats, Wistar
D000318:Adrenergic beta-Agonists; D017570:MyoD Protein; D018995:Myosin Heavy Chains; D002976:Clenbuterol